Company profileTRCC is a multinational chemical and Technology Company doing business on five continents, with manufacturing facilities throughout the world. With 2 manufacturing sites in Canada (Brampton, On, and Saint-Jean-Sur-Richelieu, Qc.), TRCC’s Canadian division offers highly customized contract manufacturing, transloading, repacking, storage, heating, and distribution services for a vast array of industries and applications including coatings, adhesives, rigid and flexible polyurethane systems and components. It remains a dominant player supporting the carpet and rug mill industry in Canada for which it develops various coating systems comprised of natural and synthetic rubber emulsions, acrylics, PVC, with and without fire retardant properties, all of which are custom-made to suit the specific needs of residential, commercial and institutional applications.

Retec International Inc, a company fully owned by TRCC Canada, combines the strong intellectual properties, technologies, and the trademarks acquired from Le Groupe de Recherche I.D., RETEC F3 Technologies and RETEC Inc, and the operational strength of TRCC Canada.
There are more than 5 million tons of buried packaging treated annually in North America. This amounts to more than 60 million trees annually. Although it represents only 4% of the world population, North America consumes a quarter of the planet's natural resources.The mission of RETEC International Inc. is to develop new products and technologies for the paper and packaging industries and replace targeted barrier materials consisting of LDPE, wax, silicon, and fluorocarbon based systems, with which coated paper end up in landfills while some of them are increasingly raising health concerns among the public and various governmental agencies. We have existing solutions offering superior performances at competitive prices with existing technologies.Retec International Inc has an enviable portfolio of water based functional barriers targeting the paper packaging industry with a strong emphasis on food, offering outstanding performances with water resistance, grease resistance, moisture vapor transmission resistance, alone or in combination, with or without heat sealable properties. Our technologies can be applied over printed materials or printed on, and require minimal thermal energy during the coating process, because of our novel and patented fast film formation technology. More importantly, paper coated with RETEC International Inc technologies can be repulped and used to make new paper. Unlike all other players in the industry, RETEC International Inc offers a cradle to cradle business model.An imminent radical change is coming to the paper packaging industry. Do not miss the boat. Give us a call

CCSPA is a national trade association representing the consumer, industrial and institutional specialty products industry. Our mission is to enhance the ability of member companies to conduct business fairly, ethically and effectively by fostering industry cooperation, providing a national voice for communications and developing effective partnerships with governments, other stakeholders and the public.

Company ProfileSME part of a private equity holding company fabricating, distributing and marketing branded and private label household and institutional cleaning, disinfectant and pest control products.General functionsResponsible for Strategic sourcing, R&D, Regulatory Affairs, Quality Control, Quality Assurance, EH&S requirements (Montreal and Toronto sites), and Technical Support to the private brands. First contact of the corporation with various municipal, provincial and federal ministries. Reports to the Senior Vice-President/General Manager of the corporation.

Company profilePrivately owned multisite SME involved in the private label market segment of the pharmaceutical industry.General functionsLead the departments of research and development, regulatory affairs, quality assurance, and quality control. Highly involved with the business processes pertaining to the commercialization of new products, including generic drugs requiring clinical trials. Main contact of the corporation with the regulatory agencies.

General functionsHeaded all the manufacturing work centers (picking, weighing, mixing, compression, encapsulation, coating), packaging, R&D, validation, Sanitation, and Buildings & Maintenance. Responsible for a unit comprised of over 150 employees, managerial and staff, in a unionized environment.

General functionsManagement of the development and the deployment of a master validation plan as well as various supporting quality systems. Setting up of the department and of the validation team. Responsible for hiring, training and developing the team members.

Company profilePrivately owned small and medium enterprise evolving in the pharmaceutical industry, Sabex inc. was a leader in the fabrication and in the distribution of pharmaceutical injectable generic drugs. Founded in 1980, Sabex was focusing on the development, the fabrication and the distribution of pharmaceutical injectable generic drugs as well as ophthalmic products, suppositories and other pharmaceutical products in Canada, the United-States of America and other international markets. Sabex Inc. was acquired by Sandoz in 2004 such that Sandoz could obtain an interesting international growth hub in the rapidly expanding market sector of injectable generic drugs while benefiting of FDA approved assets.General functionsMandate focusing on the qualification and validation of new manufacturing areas built with the goal to expand manufacturing capacity to support a targeted international expansion onto the US market. Collaborative work with various internal and external stakeholders to ensure the smooth and timely execution of various projects pertaining to cleaning validation processes, qualification of processing equipment and utilities. Reported to the Validation Manager.

Company profileBorn from the merger between Ciba and Geigy, Ciba-Geigy was a transnational enterprise diversified in many industry sectors, including the production of drug products. Among their product portfolio lied Voltaren, commercialized in 1973, as well as Ritalin, a product intended for the treatment of hyperactivity and that was commercialized in the 80’s. In 1996, Sandoz and Ciba‑Geigy Ltd integrate to form Novartis.General functionsMandate focusing on cleaning and process validation as well as on various special projects aiming at supporting other groups of the organization such as R&D, engineering, production and quality control. Reported to the laboratory manager.